Get the Daily Brief
Latest Biotech News
China’s Efficient Biotech Hub Challenges US Dominance
China’s biotechnology sector, particularly centered in Wuxi near Shanghai, is rapidly expanding its capabilities in drug development and manufacturing, focusing on cost reduction and speed rather...
Breakthrough Imaging Captures Human Embryo Implantation Real Time
Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital achieved the first real-time, 3D visualization of human embryo implantation. Using a synthetic uterine...
Hatteras Secures $200M Amid Biotech Fundraising Challenges
In a challenging fundraising environment for venture capital, Hatteras Venture Partners successfully closed two new funds totaling $200 million to invest in seed- and early-stage biotech...
FDA Approves Jazz Pharma’s Drug for Rare Brain Tumor
The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals' new treatment for a rare brain tumor, offering a novel therapeutic option for patients with limited alternatives. This...
New Insights into Immune Regulation Challenge Therapeutic Paradigms
Recent research reveals complex interactions between regulatory T cells (Tregs) and pro-inflammatory Th17 cells mediated by cytokines IL-2, TGF-β, and IL-6, uncovering paradoxical mechanisms in...
Phase II Trial Shows Nab-Paclitaxel Combo Beats Gemcitabine in Biliary Cancer
A multicenter randomized phase II study published in BMC Cancer demonstrated that nab-paclitaxel combined with cisplatin outperforms gemcitabine monotherapy in treating advanced biliary tract...
Made Scientific Unveils Expanded GMP Facility for Cell Therapy Manufacturing
Made Scientific inaugurated a new 60,000-square-foot GMP manufacturing and headquarters facility in Princeton, NJ, marking a $12 million investment to support clinical-to-commercial scale cell...
Innovative CUT&Tag Buffer Adjustment Enables Transcription Factor Profiling
Scientists at the University of Cologne developed 'DynaTag,' a refinement of the CUT&Tag assay that reduces salt concentration to capture transient transcription factor binding on DNA. This...
Kriya Therapeutics Raises $313M to Advance Gene Therapy Pipeline
Kriya Therapeutics, a gene therapy biotech with operations in North Carolina and California, secured $313 million in a recent funding round to accelerate its development of gene therapies...
FDA Signals Flexible Rare Disease Approval with Precigen Case
The FDA’s recent decision allowing Precigen to bypass certain accelerated approval and confirmatory trial requirements for a rare disease therapy signals potential shifts in regulatory...
Human embryo implantation: First 3D real-time capture
Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital have achieved the milestone of recording human embryo implantation live and in three dimensions for the...
FDA grants full approval to Precigen’s rare disease gene therapy
Precigen Inc. received swift and full FDA approval for its gene therapy Papzimeos (zopapogene imadenovec), designed to treat adults with recurrent respiratory papillomatosis, a rare cancer-like...
Pfizer’s sickle cell drug fails critical Phase 3 trial
Pfizer disclosed that its sickle cell disease candidate, inclacumab, failed to demonstrate a significant reduction in vaso-occlusive crises compared to placebo in a pivotal Phase 3 trial. This...
Hatteras Venture Partners closes $200M for early-stage biotech funds
Despite a challenging fundraising environment, Hatteras Venture Partners successfully closed two new funds totaling $200 million targeting seed and early-stage biotech companies. This injection of...
CUT&Tag method adjusted to reveal transcription factor binding
Researchers at the University of Cologne have optimized the CUT&Tag assay by lowering salt concentrations, enabling detection of transient transcription factor-DNA interactions previously masked....
Biopharma Financing Trends: Record Deals with Fewer IPOs
Biopharma deal activity in 2025 has surged to record levels, with $164 billion in transactions in the first seven months, reflecting robust mergers and financings despite a drought in IPOs....
Nanoparticle and nanomaterial innovations in therapy and energy
Recent advances spotlight titanate nanotubes enhancing lithium-ion battery anodes for energy storage, and biosilica nanoparticles offering protection against liver ischemia-reperfusion injury by...
Immunotherapy and cancer metabolic reprogramming insights
New studies elucidate mechanisms driving cancer immune responses and chemoresistance, including how regulatory T cells amplify pro-inflammatory Th17 cells via IL-2, metabolic rewiring by androgens...
Neonatal lung disease trials expand globally
Airway Therapeutics announced expansion of its Phase III trial of zelpultide alfa, a recombinant surfactant protein D analog, in preterm neonates with bronchopulmonary dysplasia. The multinational...
Reinstatement of childhood vaccine safety task force amid controversy
The U.S. Department of Health and Human Services has revived the Task Force on Safer Childhood Vaccines after nearly three decades of dormancy, prompted by a lawsuit from an anti-vaccine group...